|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:bfsLayer
|
5
|
|
gptkbp:bfsParent
|
gptkb:carbamazepine
|
|
gptkbp:approves
|
gptkb:1974
gptkb:FDA
|
|
gptkbp:brand
|
gptkb:Carbatrol
gptkb:Equetro
Tegretol XR
|
|
gptkbp:category
|
gptkb:D
gptkb:L3
|
|
gptkbp:clinical_trial
|
NC T00000123
NC T00000456
NC T00000789
NC T00001012
NC T00001345
|
|
gptkbp:contraindication
|
hypersensitivity to carbamazepine
bone marrow depression
|
|
gptkbp:discovered_by
|
gptkb:John_C._Mc_Donald
|
|
gptkbp:form
|
gptkb:tablet
suspension
extended-release tablet
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Tegretol
|
|
gptkbp:ingredients
|
gptkb:carbamazepine
C15 H12 N2 O
|
|
gptkbp:interacts_with
|
gptkb:warfarin
oral contraceptives
MAO inhibitors
other anticonvulsants
|
|
gptkbp:is_atype_of
|
N03 A F01
|
|
gptkbp:is_available_on
|
generic
|
|
gptkbp:is_used_for
|
gptkb:psychologist
bipolar disorder
trigeminal neuralgia
|
|
gptkbp:legal_issue
|
prescription only
|
|
gptkbp:lifespan
|
25 to 65 hours
|
|
gptkbp:manager
|
oral
|
|
gptkbp:marketed_as
|
gptkb:Mylan
gptkb:Teva_Pharmaceuticals
gptkb:Sandoz
gptkb:Novartis
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:packaging
|
gptkb:beer
blister pack
|
|
gptkbp:side_effect
|
dizziness
nausea
drowsiness
dry mouth
blurred vision
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:type_of
|
298-46-4
|